Disease/Infection News

RSS

Gilead Sciences to donate $8M in visceral leishmaniasis drug to WHO

Gilead Sciences, Inc. "will donate 445,000 vials of AmBisome over five years to help the World Health Organization (WHO) treat more than 50,000 patients with visceral leishmaniasis (VL), also known as kala-azar," a Gilead press release states, adding, "If sold at Gilead's no-profit access price, today's donation would cost more than $8 million."

9 Dec 2011

MSU researcher uses MRI to unlock how cerebral malaria damages brain

Building on a quarter century of work in Malawi, a Michigan State University researcher is traveling to neighboring Zambia to perform MRI scans on children newly diagnosed with cerebral malaria in hopes of unlocking how it damages the brain.

9 Dec 2011

Innovative taxes can be used to fill AIDS funding gap, UNAIDS head says

UNAIDS Executive Director Michel Sidibe told Reuters in an interview on Wednesday that donors looking to fund the fight against AIDS "could raise funds through taxes," according to the news agency.

9 Dec 2011

Genetically identical Salmonella appear in 2 types, each with an infective advantage

An unusual regulatory mechanism that controls the swimmer/non-swimmer option in genetically identical Salmonella also impacts the bacteria's ability to cause infection.

9 Dec 2011

Nighttime-lights imagery can pinpoint disease hotspots

Normally used to spot where people live, satellite images of nighttime lights can help keep tabs on the diseases festering among them, too, according to new research.

9 Dec 2011

Global health R&D funding from wealthy nations fell 6% in 2010, annual G-FINDER report finds

"A group that tracks funding for neglected diseases released its fourth annual report Wednesday, showing for the first time since 2007 a decrease in government and public spending in global health research and development," the Center for Global Health Policy's "Science Speaks" blog reports.

8 Dec 2011

House hearing on malaria progress, challenges

This post in the "Malaria Policy Center" blog describes a hearing of the House Foreign Affairs Subcommittee on Africa, Global Health, and Human Rights, titled "Fighting Malaria: Progress and Challenges," that was held on Monday.

8 Dec 2011

AIDS.gov blog posts mHealth Summit update

This post by AIDS.gov Director Miguel Gomez in the AIDS.gov blog provides an update on the second day of the mHealth Summit taking place in Washington, D.C.

8 Dec 2011

Global plan of action needed to end AIDS

After "President Obama threw the full weight of the U.S. government behind a vision" to end the AIDS epidemic in a World AIDS Day speech, "[n]ow the question is: How will we achieve this goal? What are the priority actions to take today, tomorrow, and years from now?" Mitchell Warren, executive director of AVAC: Global Advocacy for HIV Prevention, writes in the Huffington Post's "Impact" blog.

8 Dec 2011

Myanmar appeals for assistance in HIV/AIDS fight, develops 5-year national HIV/AIDS

"Myanmar appealed on Tuesday to the international community to increase assistance in combating HIV/ AIDS, as AIDS response in the country has entered a critical stage," Xinhua reports, adding, "The appeal was made by participants attending" a round-table discussion on reaching zero AIDS-related stigma and discrimination in the country.

8 Dec 2011

Inviragen presents DENVax Phase 1 trial results on dengue at ASTMH annual meeting

Inviragen, Inc. presented results of the Phase 1 clinical trial of DENVax conducted in Colombia at the annual American Society of Tropical Medicine and Hygiene (ASTMH) meeting today.

8 Dec 2011

MENA region among top two regions with fastest growing HIV epidemic, report shows

"A report on the HIV epidemic in the Middle East and North Africa (MENA) shows that while the overall HIV prevalence in the region is still low, the rise in new infections since 2001 has put the MENA region among the top two regions in the world with the fastest growing HIV epidemic," UNAIDS reports.

8 Dec 2011

BCX4945 proves effective at clearing malaria infections

An antimalarial agent developed by researchers at Albert Einstein College of Medicine of Yeshiva University proved effective at clearing infections caused by the malaria parasite most lethal to humans - by literally starving the parasites to death. The novel research, carried out on a small number of non-human primates, could bolster efforts to develop more potent therapies against one of the world's leading killers.

8 Dec 2011

ISARIC aims to prepare clinical research community for next influenza pandemic

An international consortium aimed at ensuring that the clinical research community is better prepared for the next influenza pandemic or other rapidly emerging public health threat is launched today by leading funders of medical research from across the globe.

8 Dec 2011

PrEP shows promise against HIV infection

A new weapon has emerged to prevent HIV infection. Called pre-exposure prophylaxis, or PrEP, it is a strategy of providing medications to at-risk people before they are exposed to the virus. Having shown great promise in recent phase 3 clinical trials, PrEP may soon be rolled out for public use.

8 Dec 2011

Fatal snakebites 'vastly underreported,' researchers report at annual ASTMH meeting

"Fatal snakebites worldwide have been vastly underreported because many die before seeking or reaching medical care, researchers" from the Biodiversity and Climate Research Centre in Frankfurt, Germany, reported on Monday at the American Society of Tropical Medicine and Hygiene's (ASTMH) annual meeting, UPI.com writes.

8 Dec 2011

Obama administration to promote and protect LGBT rights through foreign aid, diplomacy

"The Obama administration said Tuesday that it will intensify efforts to fight discrimination against lesbians, gay men, bisexuals and transgender people as a major element of its foreign policy," the Washington Post reports.

8 Dec 2011

Olympus releases Acecide-C High-Level Disinfectant and Sterilant

Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announces the release of Acecide-C, a new, peracetic acid-based high-level disinfectant and sterilant.

From Evident Corporation - Life Sciences 8 Dec 2011

CSL partners with NIH to study Cytomegalovirus, a common cause of abnormalities in newborns

CSL Limited announced today that it is partnering with the world’s largest health research agency, the US National Institutes of Health (NIH), to study a potential new treatment for the prevention of congenital CMV infection, one of the most common known causes of congenital (i.e., present at birth) abnormalities in the developed world.

7 Dec 2011

Vaccine against Ebola developed

Ebola was first identified in 1976 in Sudan and Zaire, which is now the Democratic Republic of the Congo and Ebola fever kills more than 90% of the people it infects. Ebola is among the most lethal diseases known to humans, according to the World Health Organization.

7 Dec 2011

Disease/Infection News

Gilead Sciences to donate $8M in visceral leishmaniasis drug to WHO

MSU researcher uses MRI to unlock how cerebral malaria damages brain

Innovative taxes can be used to fill AIDS funding gap, UNAIDS head says

Genetically identical Salmonella appear in 2 types, each with an infective advantage

Nighttime-lights imagery can pinpoint disease hotspots

Global health R&D funding from wealthy nations fell 6% in 2010, annual G-FINDER report finds

House hearing on malaria progress, challenges

AIDS.gov blog posts mHealth Summit update

Global plan of action needed to end AIDS

Myanmar appeals for assistance in HIV/AIDS fight, develops 5-year national HIV/AIDS

Inviragen presents DENVax Phase 1 trial results on dengue at ASTMH annual meeting

MENA region among top two regions with fastest growing HIV epidemic, report shows

BCX4945 proves effective at clearing malaria infections

ISARIC aims to prepare clinical research community for next influenza pandemic

PrEP shows promise against HIV infection

Fatal snakebites 'vastly underreported,' researchers report at annual ASTMH meeting

Obama administration to promote and protect LGBT rights through foreign aid, diplomacy

Olympus releases Acecide-C High-Level Disinfectant and Sterilant

CSL partners with NIH to study Cytomegalovirus, a common cause of abnormalities in newborns

Vaccine against Ebola developed

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News